| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/01/2011 | CN101084914B Application of ophiopognin saponin D in preparing medicine for regulating vascular endothelial cells apoptosis gene |
| 05/31/2011 | USRE42412 Materials and methods for the treatment of gastroesophageal reflux disease |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951805 Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | US7951777 administering one or more of vasoactive intestinal peptide (VIP) and active fragment(s) fortherapeutic treatment of myocardial fibrosis or an associated condition in a patient |
| 05/31/2011 | US7951137 Method and system for terminating an atrial arrhythmia |
| 05/31/2011 | CA2649775C Pyridine[3,4-b]pyrazinones |
| 05/31/2011 | CA2598821C Organoselenium containing compounds and their use |
| 05/31/2011 | CA2586473C Uniform drug delivery therapy |
| 05/31/2011 | CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/31/2011 | CA2443488C Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 05/31/2011 | CA2412501C Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 05/31/2011 | CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc) |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/26/2011 | WO2011063400A1 Nitroxyl donors for the treatment of pulmonary hypertension |
| 05/26/2011 | WO2011063339A1 Nitroxyl donors for the treatment of pulmonary hypertension |
| 05/26/2011 | WO2011063164A2 Sustained release cannabinoid medicaments |
| 05/26/2011 | WO2011062906A2 Treatment of atrial fibrillation |
| 05/26/2011 | WO2011062903A2 Slow infusion of sulcardine and its salts |
| 05/26/2011 | WO2011062864A2 Inhibitors of nox enzymes and methods of use thereof |
| 05/26/2011 | WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | WO2011062194A1 Aminopyridine derivative |
| 05/26/2011 | WO2011061743A1 Metadoxine and derivatives thereof for use in the treatment of inflammation and immune-related disorders |
| 05/26/2011 | WO2011061667A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 05/26/2011 | WO2011061168A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| 05/26/2011 | WO2011060746A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 05/26/2011 | WO2011060513A1 PHARMACEUTICAL COMPOSITION COMPRISING CINCHONAINS Ia AND Ib, PROCESS FOR PREPARING AN EPIMERIC MIXTURE OF CINCHONAINS Ia AND Ib, USE AND METHOD FOR REVERTING/COMBATING VENTRICULAR FIBRILLATION |
| 05/26/2011 | WO2011060492A1 Combination for treating metabolic disorders |
| 05/26/2011 | WO2011039388A3 3-indazolyl ether family with cannabinoid and/or cholinergic properties |
| 05/26/2011 | WO2011028406A3 Soaking agent for the treatment of hemorrhoids and method of use |
| 05/26/2011 | WO2011019221A3 Agent for stimulating mobilization of endothelial progenitor cells |
| 05/26/2011 | WO2011008996A3 Peptides whose uptake in cells is controllable |
| 05/26/2011 | US20110124732 Deuterium-enriched disufenton |
| 05/26/2011 | US20110124724 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potasium level in the blood |
| 05/26/2011 | US20110124716 Ultrasound-assisted gene transfer to salivary glands |
| 05/26/2011 | US20110124714 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124708 Rnai-mediated inhibition of ocular hypertension targets |
| 05/26/2011 | US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process |
| 05/26/2011 | US20110124697 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124684 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase |
| 05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
| 05/26/2011 | US20110124678 Treatment with alpha 7-selective ligands |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124665 Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof |
| 05/26/2011 | US20110124664 Polycationic Compounds And Uses Thereof |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124655 Kmup-1 capable of treating hypertension |
| 05/26/2011 | US20110124653 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 05/26/2011 | US20110124646 Novel cyclic compound having pyrimidinylalkylthio group |
| 05/26/2011 | US20110124645 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124624 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124615 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 05/26/2011 | US20110124584 Compositions and methods for treating diseases |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124572 Syndecan-4 is a regulator of rac1-gtp |
| 05/26/2011 | US20110124569 Macrocyclic compounds, protease inhibition, and methods of treatment |
| 05/26/2011 | US20110124568 Use of heat-shock protein 27 for cardiovascular disease prevention and treatment |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124560 Foxp3 oligomerization and intermolecular interactions |
| 05/26/2011 | US20110124559 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/26/2011 | US20110124558 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 05/26/2011 | US20110124550 Thymosin beta 4 promotes wound repair |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123615 Solid pharmaceutical composition |
| 05/26/2011 | US20110123612 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
| 05/26/2011 | US20110123608 Pharmaceutical formulation |
| 05/26/2011 | US20110123604 Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| 05/26/2011 | US20110123599 Aroma therapy patch |
| 05/26/2011 | US20110123594 Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent |
| 05/26/2011 | US20110123593 Self-fixating scaffolds |
| 05/26/2011 | US20110123575 Modified release niacin formulations |
| 05/26/2011 | US20110123572 Activated fibroblasts for treating tissue and/or organ damage |
| 05/26/2011 | US20110123548 Compositions and methods for the treatment and diagnosis of immune disorders |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123525 Anti-angiogenic therapy |
| 05/26/2011 | US20110123521 Methods for modulating expression of rbp4 |
| 05/26/2011 | US20110123506 Dietary health food composition, package and method of use |
| 05/26/2011 | US20110123505 Method of producing reduced coenzyme q10 and method of stabilizing the same |
| 05/26/2011 | US20110123500 Methods of isolating non-senescent cardiac stem cells and uses thereof |
| 05/26/2011 | US20110123495 Derivatives of pyridone and use thereof |
| 05/26/2011 | US20110123481 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 05/26/2011 | US20110123466 Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome c |